TNF-α and genetic susceptibility to parasitic disease

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 300-303

  Goldfeld, Anne E ^a   Tsai, Eunice Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

GENETIC SUSCEPTIBILITY; HUMAN; IMMUNITY; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030298520     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0117     Document Type: Article

References (17)

1. GARCIA, I., MIYAZAKI, Y., ARAKI, K., ARAKI, M., LUCAS, R., GRAU, G. E., MILON, G., BELKAID, Y., MON-TIXI, C., LESSLAUER, W., AND VASSALLI, P. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. European Journal of Immunology 25, 2401-2407.
2. TSAI, E. Y., YIE, J., THANOS, D., AND GOLDFELD, A. 1996. Cell-type-specific regulation of the human tumor necrosis factor-alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Molecular and Cellular Biology 16, 5232-5244.
3. MCGUIRE W, HILL, A. V. S., ALLSOPP, C. E. M., GREENWOOD, B. M., KWIATOWSKI, D. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371(6), 508-511.
4. CABRERA, M., SHAW, M.-A., SHARPLES, C., WILLIAMS, H., CASTES, M., CONVIT, J., AND BLACKWELL, J. M. 1995. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. Journal of Experimental Medicine 182, 1259-1264.
5. WILSON, A. G., SYMONS, J. A., MCDOWELL, T. L., DI GIOVME, F. S., AND DUFF, G. W. 1994. Effects of a tumor necrosis factor (TNFα) promoter base transition on transcriptional activity. British Journal of Rheumatology 33(Suppl. 1), 89.
6. BRINKMAN, B. M. N., ZUIJDGEEST, D., KAIJZEL, E. L., BREEDVELD, F. C., AND VERWEIJ, C. L. 1996. Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. Journal of Inflammation 46, 32-41.
7. STUBER, F., UDALOVA, I. A., BOOK, M., DRUTSKAYA, L. N., KUPRASH, D. V., TURETSKAYA, R. L., SCHADE F. U., NEDOSPASOV, S.A. 1996. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. Journal of Inflammation 46, 42-50.
8. HILL, A. V. S. "Host Genetics of Malaria and Tuberculosis." 4th Int. Nature Genetics Conference, April 17-19, 1996, Vancouver, BC, Canada.
9. DROUET, C., SHAKHOV, A. N., JONGENEEL, C. V. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. Journal of Immunology 147(5), 1694-1700.
10. POCIOT, F., D'ALFONSO, S., COMPASSO, S., SCORZA, R., RICHIARDI, P. M. 1995. Functional analysis of a new polymorphism in the human TNF-α gene promoter. Scandinavian Journal of Immunology 42, 501-504.
11. BARINAGA, M. 1996. Forging a path cell to death. Science 273(9), 735-737.
12. GRELL, M., DOUNI, E., WAJANT, H., LOHDEN, M., CLAUSS, M., MAXEINER, B., GEOGOPOULOS, S., LESSLAUER, W., KOLLIAS, G., PFIZENMAIER, K., AND SCHEURICH, P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
13. LUCAS, R., JUILLARD, P., REDARD, M., DONATI, Y. R. A., LOU, J.-N., DECRIEND, C., MONSO-HINARD, C., ZHENG, L., DE KESEL T., BUURMAN, W., MOORE, M. W., BLUETHMANN, H., AND GRAU, G. E. 1996. Lack of TNF receptor 2, but not of TNFR1 protects mice from experimental cerebral malaria. European Cytokine Network 7(2), 247.
14. MARINO, M. W., OLD, L. J., GRAIL, D., INGLESE, M., NOGUCHI, Y., WADA, H., RICHARDS, E., JUNGBLUTH, A., MOORE, M., BERNARD, E., WILLIAMSON, B., RYFFEL, B., AND DUNN, A. R. Initial characterization of TNF-α knock-out mice. Proceedings of the National Academy of Science USA, submitted for publication.
15. PASPARAKIS, M., ALEXOPOULOU, L., KOLLIAS, G. "A Critical Role for TNFα in Germinal Centre Formation and in the Development of the Marginal Zone Revealed in TNFα Knockout Mice. International Cytokine Soci-ety and International Society for Interferon and Cytokine Research. October 6-10, 1996, Geneva Switzerland.
16. LE HIR, M., BLUETHMANN, H., KOSCO-VILBOIS, M. H., MÏLLER, M., DI PADOVA, F., MOORE, M., RYFFEL, B., EUGSTER, H.-P. 1996. Differentiation of follicular dendritic cells (FDC) and full antibody responses require TNF receptor-1 (TNFR1) signalling. Journal of Experimental Medicine 183, 2367-2372.
17. BOUSSIOTIS, V. A., NADLER, L. M., STROMINGER, J. L., GOLDFELD, A. E. 1994. Tumor necrosis factor α is an autocrine growth factor for normal human B cells. Proceedings of the National Academy of Science USA 91, 7007-7011.